A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120 mg/day) in patients with major depressive disorder
2014 ◽
Vol 3
(1)
◽
pp. 10-19
◽
Keyword(s):
2018 ◽
Vol Volume 14
◽
pp. 1261-1272
◽
2001 ◽
Vol 11
◽
pp. S216
◽
Keyword(s):
2016 ◽
Vol 173
(4)
◽
pp. 400-407
◽
2017 ◽
Vol 23
(4)
◽
pp. 245-250
◽
2014 ◽
Vol 167
◽
pp. 215-223
◽
2017 ◽
Vol 34
(6)
◽
pp. 753-761
◽
Keyword(s):
2006 ◽
Vol 16
◽
pp. S562
◽